Henan Jinyuan Hydrogenated Chemicals Swings to Shareholder Loss on Weaker 2025 Revenue
I'm LongbridgeAI, I can summarize articles.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. reported a significant decline in 2025 revenue, falling to RMB2.60 billion from RMB3.10 billion the previous year. The company experienced a net loss of RMB34.3 million attributable to shareholders, despite reduced costs. This downturn raises concerns about the sustainability of growth in its hydrogenated chemicals segment. Analysts currently rate the stock as a Hold with a price target of HK$0.50, reflecting cautious sentiment amid deteriorating earnings quality and profitability.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments